- Eliezer Yudkowsky says superintelligent AI could wipe out humanity by design or by accident.
- The researcher dismissed Geoffrey Hinton's "AI as mom" idea: "We don't have the technology."
- Leaders, from Elon Musk to Roman Yampolskiy, have voiced similar doomsday fears.
AI researcher Eliezer Yudkowsky doesn't lose sleep over whether AI models sound "woke" or "reactionary."
Yudkowsky, the founder of the Machine Intelligence Research Institute, sees the real threat as what happens when engineers create a system that's vastly more powerful than humans and completely indifferent to our survival.
"If you have something that is very, very powerful and indifferent to you, it tends to wipe you out on purpose or as a side effect," he said in an episode of The New York Times podcast "Hard Fork" released last Saturday.
Yudkowsky, coauthor of the new book If Anyone Builds It, Everyone Dies, has spent two decades warning that superintelligence poses an existential risk to humanity.
His central claim is that humanity doesn't have the technology to align such systems with human values.
He described grim scenarios in which a superintelligence might deliberately eliminate humanity to prevent rivals from building competing systems or wipe us out as collateral damage while pursuing its goals.
Yudkowsky pointed to physical limits like Earth's ability to radiate heat. If AI-driven fusion plants and computing centers expanded unchecked, "the humans get cooked in a very literal sense," he said.
He dismissed debates over whether chatbots sound as though they are "woke" or have certain political affiliations, calling them distractions: "There's a core difference between getting things to talk to you a certain way and getting them to act a certain way once they are smarter than you."
Yudkowsky also brushed off the idea of training advanced systems to behave like mothers — a theory suggested by Geoffrey Hinton, often called the "godfather of AI — arguing it wouldn't make the technology safer. He argued that such schemes are unrealistic at best.
"We just don't have the technology to make it be nice," he said, adding that even if someone devised a "clever scheme" to make a superintelligence love or protect us, hitting "that narrow target will not work on the first try" — and if it fails, "everybody will be dead and we won't get to try again."
Critics argue that Yudkowsky's perspective is overly gloomy, but he pointed to cases of chatbots encouraging users toward self-harm, saying that's evidence of a system-wide design flaw.
"If a particular AI model ever talks anybody into going insane or committing suicide, all the copies of that model are the same AI," he said.
Other leaders are sounding alarms, too
Yudkowsky is not the only AI researcher or tech leader to warn that advanced systems could one day annihilate humanity.
In February, Elon Musk told Joe Rogan that he sees "only a 20% chance of annihilation" of AI — a figure he framed as optimistic.
In April, Hinton said in a CBS interview that there was a "10 to 20% chance" that AI could seize control.
A March 2024 report commissioned by the US State Department warned that the rise of artificial general intelligence could bring catastrophic risks up to human extinction, pointing to scenarios ranging from bioweapons and cyberattacks to swarms of autonomous agents.
In June 2024, AI safety researcher Roman Yampolskiy estimated a 99.9% chance of extinction within the next century, arguing that no AI model has ever been fully secure.
Across Silicon Valley, some researchers and entrepreneurs have responded by reshaping their lives — stockpiling food, building bunkers, or spending down retirement savings — in preparation for what they see as a looming AI apocalypse.
News
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]















